Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Trading Statement

2 Apr 2020 07:40

RNS Number : 5522I
Thruvision Group PLC
02 April 2020
 

2 April 2020

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Pre-close statement

 

 

Thruvision (AIM: THRU), the specialist provider of people-screening technology to the international security market, is pleased to provide an update on trading for the financial year ended 31 March 2020.

 

The Group maintained good momentum through much of the second half of the year, with good revenue growth complemented by continued strategic progress in our profit protection and aviation markets. However, the recent COVID-19 pandemic has caused a material slowdown in order-flow in March, meaning full year revenues are now expected to be £8.0 million (FY19: £6.0 million), somewhat below our previous expectations.

 

Second half sales saw repeat orders from existing customers, including an Asian government and supermarket group, Morrisons, which is rolling out Thruvision units across its Distribution Centre estate. Two new profit protection customers ordered their first units, one of which, significantly, is our first in North America. We also received our first order for the Group's new higher performance 16-channel sensor from a global technology firm seeking to improve data centre security. We continued to support ongoing rollouts of units purchased by international Customs agencies in the first half of the year, and we made steady progress through ongoing US Transportation Security Administration laboratory testing and airport employee security trials.

 

Regarding COVID-19, with due regard to government advice, we have taken all necessary steps to look after the health and wellbeing of our staff. The pandemic has impacted the Group's trading in three ways. Firstly, a number of orders have been delayed as customers review their own trading positions. Secondly, a number of trials, both in the UK and overseas, have been postponed due to their inherent logistical challenges in the current climate. Finally, our current view is that our supply chain will allow us to sustain moderate production levels for the next three months. Accordingly, given the evolving nature of COVID-19, it is too early to provide guidance on the potential impact on the Group in the new financial year ending 31 March 2021.

 

We have implemented measures to tighten cash flow management over the coming months, even though we are in the fortunate position of having a healthy cash balance and zero debt. Cash at 31 March 2020 was £8.6 million, broadly unchanged from the position at 30 September 2019.

 

More positively, we are encouraged by the recent uptick in interest relating to Thruvision's unique ability to provide effective "hands off" security screening at a safe distance, without the need for physical "patdowns". We believe this aspect to our technology, our strong balance sheet and the strength and depth of our sales pipeline mean we are well positioned to continue to trade through this difficult period and we remain confident about our strategic prospects.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Shamma Kelly

 

 

 

 

About Thruvision

Thruvision Group plc is a specialist provider of people-screening technology that can safely see weapons, explosives and contraband hidden in peoples' clothing. Developed with extensive support from the British and US Governments, Thruvision technology is operationally proven and is being used to enhance the security of transport hubs, borders, high profile buildings and public areas.

 

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFZGGDVZNGGZG
Date   Source Headline
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSSharesave option grant to Executive Director
8th Oct 20192:00 pmRNSAward of Share Options to Executive Directors
3rd Oct 20197:00 amRNSTrading Update
23rd Sep 20191:29 pmRNSResult of Annual General Meeting
23rd Sep 20197:00 amRNSContract award announcement
16th Sep 20193:36 pmRNSThruvision trialed in London Underground station
8th Jul 20192:14 pmRNSNotice of Audited Results
24th Jun 20197:00 amRNSResults for the Year ended 31 March 2019
20th Jun 20197:00 amRNSNotice of Results
22nd May 20197:00 amRNSContract award announcement
1st May 20197:00 amRNSAppointment of Finance Director
2nd Apr 20197:00 amRNSPre-close Trading Update
7th Feb 20197:00 amRNSCapital Markets Day
18th Jan 20194:02 pmRNSAward of Share Options to Executive Directors
10th Dec 20187:00 amRNSInterim Results
3rd Dec 201812:52 pmRNSNotice of Results
2nd Nov 20181:24 pmRNSTSA Concept of Operations Development Contract
3rd Oct 20187:00 amRNSTrading Update
21st Sep 20183:57 pmRNSSharesave option grant to Executive Directors
21st Sep 201810:21 amRNSAGM Statement
7th Sep 20185:10 pmRNSHolding(s) in Company
7th Sep 20185:07 pmRNSHolding(s) in Company
24th Aug 20189:19 amRNSAmendment - Holding(s) in Company
22nd Aug 201811:30 amRNSHolding(s) in Company
21st Aug 201810:52 amRNSHolding(s) in Company
20th Aug 20183:04 pmRNSHolding(s) in Company
20th Aug 20182:53 pmRNSHolding(s) in Company
9th Aug 201812:30 pmRNSAnnouncement of Results of Tender Offer
31st Jul 20189:00 amRNSHolding(s) in Company
24th Jul 201810:21 amRNSResults of General Meeting/Tender Offer
4th Jul 20187:00 amRNSProposed Tender Offer & Notice of General Meeting
26th Jun 20187:00 amRNSAudited results for the full year 31 March 2018
21st Jun 201811:26 amRNSNotice of Audited Results
1st May 20183:53 pmRNSCapital Reduction Effective
28th Mar 20183:25 pmRNSResult of General Meeting
15th Mar 20185:13 pmRNSHolding(s) in Company
15th Mar 20182:00 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAward of Share Options to Executive Director
13th Mar 20185:29 pmRNSHolding(s) in Company
13th Mar 20183:40 pmRNSHolding(s) in Company
13th Mar 20183:17 pmRNSHolding(s) in Company
12th Mar 20182:05 pmRNSSecond Price Monitoring Extn
12th Mar 20182:02 pmRNSPrice Monitoring Extension
12th Mar 20187:01 amRNSShare Premium Account & Capital Redemption Reserve
12th Mar 20187:00 amRNSTrading Update & Return of Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.